Nivolumab

Nivolumab is used in the treatment of non-small cell lung cancer, kidney cancer, head and neck cancer, melanoma, Hodgkin’s disease and liver cancer.

Nivolumab is an anti-cancer medication. It works by blocking a protein (PD-1) on the surface of certain immune cells called T-cells. This action activates the T-cells to locate and kill cancer cells.

Musculoskeletal (bone, muscle or joint) pain, Upper respiratory tract infection, Fever, Pneumonia, Bronchitis (inflammation of the airways), Infusion site reaction, Hypersensitivity, Decreased level of thyroid hormones, Hyperthyroidism, Inflammation of the thyroid gland, Increased glucose level in blood, Hypoglycemia (low blood glucose level), Peripheral neuropathy (tingling and numbness of feet and hand), Cardiac disturbances, Gastrointestinal disturbance, Colitis, Stomatitis (Inflammation of the mouth), Joint pain, Fatigue, Edema (swelling), Chest pain, Increased aspartate aminotransferase, Low albumin level in blood, Increased alkaline phosphatase level in blood, Decreased white blood cell count (lymphocytes), Decreased white blood cell count (neutrophils), Low blood platelets, Electrolyte imbalance